Also categorized in BoardMoves:
Pandora Jewelry Names New CEO and Board Chairman
x hide permanently

ADMA Biologics Announces Martha J. Demski Elected to Board of Directors


ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the proposed resolution to elect Martha J. Demski to its Board of Directors was approved at the Company’s recent Annual Shareholder Meeting, held June 18, 2020...

Mentions: Bank of America Nasdaq Adamas